Moderna Stock Skids After 2023 Guidance Misses Over $2 Billion | Investor Business Daily – Investor Business Daily

Leave a Comment / Business / By
  1. Moderna Stock Skids After 2023 Guidance Misses Over $2 Billion | Investor’s Business DailyInvestor’s Business Daily
  2. Moderna misses out on profit as costs rise due to excess production capacity, drop in demand for Covid shotsCNBC
  3. Slump in COVID-19 vaccine sales weighs on Moderna’s fourth-quarter resultsYahoo finance
  4. Declining vaccine sales, new costs, Moderna 4Q profit squeezeYahoo finance
  5. Moderna, on its heels, reassures investors on flu vaccine after mixed phase 3 dataFierceBiotech
  6. See full coverage on Google News

Leave a Comment

Your email address will not be published. Required fields are marked *